Literature DB >> 6298476

Ketoconazole therapy for fungal urinary tract infections.

J R Graybill, J N Galgiani, J H Jorgensen, D A Strandberg.   

Abstract

Ketoconazole was used in 11 patients to treat 12 episodes of fungal urinary infections: 6 in the upper urinary tract and 6 presumed to be in the lower urinary tract. Five patients had catheters in place. Of the 12 infections 8 were caused by Candida species, 1 by mixed Candida tropicalis and Torulopsis glabrata, and 3 by Torulopsis glabrata. Ketoconazole was administered orally at doses of 200 to 800 mg. per day for courses ranging from 5 days to more than 2 years. Five episodes of Candida urinary tract infection resolved in association with ketoconazole therapy, while only 1 of the Torulopsis glabrata infections improved. Our findings suggest that ketoconazole may be of some benefit in yeast urinary tract infections. However, the role of ketoconazole in relation to other antifungal drugs is not yet clear.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6298476     DOI: 10.1016/s0022-5347(17)51922-9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

Review 1.  New antifungal agents.

Authors:  J R Graybill
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-05       Impact factor: 3.267

2.  Ureteral blockage by Candida in a patient with urinary derivation type Camey.

Authors:  R G Aguilera; R R Aldosa; G Rius-Espina; J P López
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

3.  Candida tropicalis infection in normal, diabetic, and neutropenic mice.

Authors:  R A Fromtling; G K Abruzzo; D M Giltinan
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

4.  Collaborative evaluation in seven laboratories of a standardized micromethod for yeast susceptibility testing.

Authors:  R Guinet; D Nerson; F de Closets; J Dupouy-Camet; L Kures; M Marjollet; J L Poirot; A Ros; J Texier-Maugein; P J Volle
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

Review 5.  Clinical pharmacokinetics of ketoconazole.

Authors:  T K Daneshmend; D W Warnock
Journal:  Clin Pharmacokinet       Date:  1988-01       Impact factor: 6.447

Review 6.  Management of candiduria.

Authors:  J D Sobel; T Lundstrom
Journal:  Curr Urol Rep       Date:  2001-08       Impact factor: 2.862

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.